Amandine Daban-Conte

LCC, 205 Route De Narbonne, BP 44099, Cedex 4
Toulouse, 31077, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Unexpected Trends in Copper Removal from Aβ Peptide: When Less Ligand Is Better and Zn Helps.

Unexpected Trends in Copper Removal from Aβ Peptide: When Less Ligand Is Better and Zn Helps.

Journal: Inorganic chemistry

Published: January 05, 2021

An easy-to-implement combinatorial approach involving an activity-based assay for the discovery of a peptidyl copper complex mimicking superoxide dismutase.

An easy-to-implement combinatorial approach involving an activity-based assay for the discovery of a peptidyl copper complex mimicking superoxide dismutase.

Journal: Chemical communications (Cambridge, England)

Published: December 11, 2019

Copper-Targeting Approaches in Alzheimer's Disease: How To Improve the Fallouts Obtained from in Vitro Studies.

Copper-Targeting Approaches in Alzheimer's Disease: How To Improve the Fallouts Obtained from in Vitro Studies.

Journal: Inorganic chemistry

Published: June 29, 2019

Corrigendum: Kinetics Are Crucial When Targeting Copper Ions to Fight Alzheimer's Disease: An Illustration with Azamacrocyclic Ligands.

Corrigendum: Kinetics Are Crucial When Targeting Copper Ions to Fight Alzheimer's Disease: An Illustration with Azamacrocyclic Ligands.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: September 04, 2018

Kinetics Are Crucial When Targeting Copper Ions to Fight Alzheimer's Disease: An Illustration with Azamacrocyclic Ligands.

Kinetics Are Crucial When Targeting Copper Ions to Fight Alzheimer's Disease: An Illustration with Azamacrocyclic Ligands.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: March 26, 2018

A Metallo Pro-Drug to Target CuII in the Context of Alzheimer's Disease.

A Metallo Pro-Drug to Target CuII in the Context of Alzheimer's Disease.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: December 20, 2017

Mutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level.

Mutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: September 23, 2017

A Trishistidine Pseudopeptide with Ability to Remove Both CuΙ and CuΙΙ from the Amyloid-β Peptide and to Stop the Associated ROS Formation.

A Trishistidine Pseudopeptide with Ability to Remove Both CuΙ and CuΙΙ from the Amyloid-β Peptide and to Stop the Associated ROS Formation.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: July 24, 2017

How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study.

How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: October 07, 2016

Zinc(II) Binding Site to the Amyloid-β Peptide: Insights from Spectroscopic Studies with a Wide Series of Modified Peptides.

Zinc(II) Binding Site to the Amyloid-β Peptide: Insights from Spectroscopic Studies with a Wide Series of Modified Peptides.

Journal: Inorganic chemistry

Published: September 27, 2016

Copper(I) targeting in the Alzheimer's disease context: a first example using the biocompatible PTA ligand.

Copper(I) targeting in the Alzheimer's disease context: a first example using the biocompatible PTA ligand.

Journal: Metallomics : integrated biometal science

Published: May 01, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026